The investigation concerns whether Skye and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. , /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ: SKYE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. CONTACT: Danielle Peyton Pomerantz LLP [email protected] 646-581-9980 ext. 7980 SOURCE Pomerantz LLP ...

Key Takeaways SKYE stock plunged 60% after nimacimab missed the primary goal in its phase IIa obesity study.The nimacimab/Wegovy combo showed greater weight loss and no safety concerns through the initial 26 weeks.Enrollment for the study's 26-week extension phase is complete, with readout planned for early 2026.Shares of Skye Bioscience (SKYE) crashed 60% on Monday after the company failed to meet the key goal in a mid-stage proof-of-concept study of its only pipeline candidate, nimacimab, for obesity.The ...

评级变动 - Craig-Hallum将Skye Bioscience的评级从买入下调至持有 股价为1.91美元[1] - 此次评级下调反映了对公司股票未来表现的谨慎立场[1] 股价表现 - 尽管纳斯达克综合指数上涨超过150点 公司股价却出现大幅下跌 当前价格为1.90美元[2] - 公司股价较前期水平显著下跌60%[2] - 当日股价在1.77美元至2.30美元之间波动[3] - 过去52周内 股价最高为5.96美元 最低为1.14美元 显示出较大波动性[3] 市场数据 - 公司当前市值约为5888万美元[4] - 股票成交量为1321万股 显示出一定的投资者关注度[4]

文章核心观点 - 近期市场分析显示多家公司股价出现大幅下跌，成为表现最差的公司 [1] - 股价变动原因包括临床试验结果不佳、业务前景不确定性以及行业特定挑战等公司层面因素 [4][5] - 涉及公司横跨医疗保健、教育和金融服务等多个行业 [6] Horizon Space Acquisition I Corp (HSPOR) - 公司股价下跌至0.12美元，跌幅约为41.77% [2] - 作为专注于并购的壳公司，股价大幅下跌表明其在实现业务目标方面面临挑战 [2] - 市场反应反映出对其能否达成重要业务合并存在不确定性 [2] Lixiang Education Holding Co Ltd (LXEH) - 公司股价下跌至0.94美元，跌幅达66.71% [3] - 尽管身处中国教育行业，公司仍面临显著的市场低迷 [3] - 公司已重新符合纳斯达克市值要求，这可能为未来提供一定稳定性 [3] Skye Bioscience Inc (SKYE) - 公司股价下跌至1.89美元，跌幅为60.20% [4] - 股价下跌紧随其nimacimab药物2a期CBeyond研究令人失望的顶线数据公布之后 [4] - 市场正在对公司最近的临床试验结果作出反应 [4] Stellar V Capital Corp Warrant (SVCCW) - 权证价格调整至0.34美元，跌幅为35.85% [5] - 作为探索收购机会的空白支票公司，市场反应不佳表明其未来收购前景存在不确定性 [5]

PresentationOperator Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to Skye Biosciences conference call to discuss Phase IIa top line clinical trial results. I would now like to turn the conference over to Bernie Hertel, Head of Investor Relations. Please go ahead. ...

PresentationI would now like to turn the conference over to Bernie Hertel, Head of Investor Relations. Please go ahead.Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to Skye Biosciences conference call to discuss Phase IIa top line clinical trial results.Bernie Hertel Good morning. Before we begin, I'd like to caution that comments made during this conference call will contain forward-looking statements under the safe harbor provisions of the U.S. Private Sec ...

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 150 points on Monday.The Dow traded down 0.16% to 46,684.03 while the NASDAQ rose 0.71% to 22,941.69. The S&P 500 also rose, gaining, 0.40% to 6,742.80.Check This Out: How To Earn $500 A Month From McCormick Stock Ahead Of Q3 EarningsLeading and Lagging SectorsInformation technology shares jumped by 0.9% on Monday.In trading on Monday, real estate stocks fell by 0.8%.Top HeadlineAdvanced Micro Devices (NASDAQ:AMD) s ...

美股市场整体表现 - 美股早盘交易涨跌互现，道琼斯指数下跌超过100点，跌幅0.23%至46,651.42点 [1] - 纳斯达克指数上涨0.37%至22,865.21点，标普500指数上涨0.20%至6,729.08点 [1] 行业板块表现 - 公用事业股表现领先，上涨0.7% [1] - 房地产股表现落后，下跌0.6% [1] 个股重大新闻 - 超微公司股价飙升超过27%，因其与OpenAI达成一项里程碑式协议，将为该科技巨头的下一代人工智能基础设施部署高达6吉瓦的AMD Instinct GPU算力 [2] - 初始阶段将于2026年下半年部署1吉瓦的AMD Instinct MI450 GPU，并计划后续扩展至多代AMD数据中心芯片 [2] - 根据协议，OpenAI将指定AMD为核心计算合作伙伴，利用其MI450系列和机架级人工智能解决方案 [3] 商品市场 - 原油价格上涨0.7%至每桶61.28美元 [6] - 黄金价格上涨1.8%至每盎司3,977.90美元 [6] - 白银价格上涨1.1%至每盎司48.485美元，铜价下跌1.4%至每磅5.0365美元 [6] 欧洲股市 - 欧洲斯托克600指数上涨0.1% [7] - 德国DAX 40指数上涨0.2% [7] - 法国CAC 40指数下跌1.4% [7] - 西班牙IBEX 35指数下跌0.1%，英国富时100指数下跌0.1% [7] 亚太股市 - 日本日经225指数大幅上涨4.75% [10] - 印度孟买Sensex指数上涨0.72% [10] - 香港恒生指数下跌0.67% [10] 其他显著异动个股 - Spruce Biosciences公司股价暴涨316%至36.73美元，因其宣布其用于治疗Sanfilippo综合征B型的酶替代疗法获得美国FDA突破性疗法认定 [9] - OneMedNet公司股价飙升143%至2.4999美元，因其宣布选择Palantir Technologies来推进其医疗人工智能和真实世界数据分析业务 [9] - Society Pass公司股价上涨113%至2.9987美元 [9] - Lixiang Education Holding公司股价下跌58%至1.19美元 [9] - Skye Bioscience公司股价下跌54%至2.18美元，因其宣布nimacimab单药治疗组未达到CBeyond研究的主要终点 [9] - Dragonfly Energy Holdings公司股价下跌28%至1.36美元，因其宣布以每股1.25美元的价格完成2500万股、总价值2500万美元的承销公开发行 [9]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Skye Bioscience Inc. (NASDAQ:SKYE) stock sank on Monday after the company released topline data from its 26-week Phase 2a CBeyond proof-of-concept study of nimacimab.The nimacimab monotherapy arm did not achieve the primary endpoint of weight loss compared to placebo (-1.52% vs. -0.26 for placebo, mITT).Preliminary pharmacokinetic analysis showed lower than expected drug exposure of nimacimab, supporting evaluation of higher dosing.Also Read: Skye Bioscience Advances Position In Competitive Obesity Market W ...